Login / Signup
SARS-CoV-2 Antibody Replacement Therapy for Immunocompromised Patients.
Jonathon W Senefeld
Michael J Joyner
Published in:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Keyphrases
</>
replacement therapy
sars cov
end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
coronavirus disease
intensive care unit
extracorporeal membrane oxygenation